BLS
BLS Pharmaceuticals Ltd
$1.01
▼ -1.46%
Market cap
$234M
Turnover
$835,724
Last price
$1.01
Day change
-1.46%
Announcements
6
Range, past year
Open 0.970 · Low 0.775 · Now 1.015 · High 1.295
Open BLS in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
BLS momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-09-28.
Momentum quality
45/100
Wyckoff phase
Accumulation3d
Trend stage
Neutral
1 Day
-1.5%
1 Week
-15.8%
1 Month
+10.3%
RSI
42
Avg daily range
6.8%
BLS Pharmaceuticals Ltd scores 45 out of 100 for momentum quality, a reading rated low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.
On the Wyckoff cycle it sits in Accumulation, where it has been for 3 trading days. The weekly timeframe reads Unknown, which does not yet agree with the daily view.
Against the wider market it is currently underperforming and the institutional accumulation signal reads low.
What stands out
- Volume 1.7× 60-day avg
Points to watch
- 60d drawdown -21.3%
- High volatility (ATR 6.8%)
- MACD histogram turning down
- Risk rating: High
- Composite downside risk elevated
BLS announcements
Recent price-sensitive releases.
- 2026-08-31 BLS FY2027 Guidance Profit Guidance | Preliminary Final Report
- 2026-08-31 BLS Investor Presentation Company Presentation | Preliminary Final Report
- 2026-08-31 BLS FY2026 Results Announcement Web Cast | Preliminary Final Report
- 2026-08-31 Annual Report to shareholders Annual Report | Top 20 shareholders | Preliminary Final Report | Full Year Accounts | Full Year Audit Review | Full Year Directors' Statement | Full Year Directors' Report
- 2026-07-30 BLS Pharmaceuticals Investor Webinar Presentation Company Presentation
- 2026-07-27 Quarterly Activities/Appendix 4C Cash Flow Report Commitments Test Entity - Fourth Quarter Activity Report | Notification of Results/Reporting Date | Commitments Test Entity - Fourth Quarter Cashflow Report
More Consumer Staples stocks
Most traded in the same sector.